Journal article
Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian Data
Abstract
AIMS: To compare biochemical failure-free survival (BFFS) and overall survival for prostate cancer treated with stereotactic ablative radiotherapy (SABR), low dose rate (LDR) brachytherapy or external beam radiotherapy (EBRT) using a large Canadian multi-institutional database.
MATERIALS AND METHODS: Patients with low risk localised prostate cancer treated with SABR, LDR or EBRT and no androgen deprivation therapy were selected. Propensity …
Authors
Loblaw A; Pickles T; Crook J; Martin A-G; Vigneault E; Souhami L; Cury F; Morris J; Catton C; Lukka H
Journal
Clinical Oncology, Vol. 29, No. 3, pp. 161–170
Publisher
Elsevier
Publication Date
March 2017
DOI
10.1016/j.clon.2016.10.001
ISSN
0936-6555